MAPT and Parkinson disease: A study investigated microglia activation, striatal dopaminergic function and acetylcholinesterase with PET imaging as well as morphologic brain changes with MRI in three presymptomatic carriers of mutation on MAPT genes, belonging to kindred affected by frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) [11].